When we think of the symptoms of major depressive disorder (MDD) we typically think of persistent feelings of sadness, lack ...

New research published in Annals of Family Medicine identifies five clinically relevant prescribing cascades in a national sample of more than half a million older adults in Ireland. The findings show ...

Solriamfetol is a dopamine and norepinephrine reuptake inhibitor (DNRI), TAAR1 agonist, and 5-HT 1A agonist being developed ...

In response to the FDA's feedback, Axsome plans to conduct an additional controlled trial that will use a fixed-dose paradigm ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

AD109 (Apnimed) is made up of 2.5 mg aroxybutynin, a novel antimuscarinic, and 75 mg atomoxetine, a selective norepinephrine reuptake inhibitor, according to a press release from Apnimed.

It is a first-in-class investigational combination of aroxybutynin, a novel antimuscarinic, and atomoxetine, a selective norepinephrine reuptake inhibitor. These compounds are designed to work ...

SSRI stands for "selective serotonin reuptake inhibitor," a class of medication ... include serotonin-norepinephrine reuptake inhibitors such as venlafaxine and duloxetine and atypical ...

Unlike stimulant-based drugs that make up the bulk of ADHD treatment, including those like Vyvanse and Adderall, atomoxetine is a selective norepinephrine reuptake inhibitor (sNRI). The recall was ...

AXS-12 (reboxetine) is Axsome’s novel, oral, investigational, highly selective and potent norepinephrine reuptake inhibitor and cortical dopamine modulator being developed for the treatment of ...

Credit: Supernus Qelbree is a selective norepinephrine reuptake inhibitor. The transfer of the drug into breastmilk was reported to be low. The prescribing information for Qelbree ® (viloxazine ...

Switching from a selective serotonin reuptake inhibitor (SSRI) to a serotonin-norepinephrine reuptake inhibitor (SNRI) is a common step for individuals whose depression isn’t fully managed with ...